Unités Mixtes de Recherche S949, INSERM, Strasbourg, France; Etablissement Français du Sang-Alsace, Strasbourg, France; Université de Strasbourg, Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France;
Unité Mixte de Recherche S1148, INSERM, Paris, France; Université Paris Diderot, Paris, France; Centre Hospitalier Universitaire Bichat, Paris, France;
Blood. 2015 Jul 30;126(5):683-91. doi: 10.1182/blood-2015-02-629717. Epub 2015 May 14.
Fibrin, the coagulation end product, consolidates the platelet plug at sites of vascular injury and supports the recruitment of circulating platelets. In addition to integrin αIIbβ3, another as-yet-unidentified receptor is thought to mediate platelet interaction with fibrin. Platelet glycoprotein VI (GPVI) interacts with collagen and several other adhesive macromolecules. We evaluated the hypothesis that GPVI could be a functional platelet receptor for fibrin. Calibrated thrombin assays using platelet-rich plasma (PRP) showed that tissue factor-triggered thrombin generation was impaired in GPVI-deficient patients and reduced by the anti-GPVI Fab 9O12. Assays on reconstituted PRP and PRP from fibrinogen-deficient patients revealed a fibrinogen-dependent enhancement of thrombin generation, which relied on functional GPVI. The effect of GPVI was found to depend on fibrin polymerization. A binding assay showed a specific interaction between GPVI-Fc and fibrin, inhibited by the Fab 9O12. This Fab also reduced platelet adhesion to fibrin at low (300 s(-1)) and high (1500 s(-1)) wall shear rates. Platelets adherent to fibrin displayed shape change, exposure of procoagulant phospholipids, and the formation of small clots. When hirudinated blood was perfused at 1500 s(-1) over preformed fibrin-rich clots, the Fab 9O12 decreased the recruitment of platelets by up to 85%. This study identifies GPVI as a platelet receptor for polymerized fibrin with 2 major functions: (1) amplification of thrombin generation and (2) recruitment of circulating platelets to clots. These so-far-unrecognized properties of GPVI confer on it a key role in thrombus growth and stabilization.
纤维蛋白是凝血的终产物,它在血管损伤部位凝聚血小板栓子,并支持循环血小板的募集。除整合素 αIIbβ3 外,另一种尚未确定的受体被认为介导血小板与纤维蛋白的相互作用。血小板糖蛋白 VI(GPVI)与胶原和其他几种黏附大分子相互作用。我们评估了 GPVI 可能是纤维蛋白的功能性血小板受体的假说。使用富含血小板的血浆(PRP)进行校准的凝血酶测定表明,组织因子触发的凝血酶生成在 GPVI 缺陷患者中受损,并被抗 GPVI Fab 9O12 降低。在重组 PRP 和纤维蛋白原缺陷患者的 PRP 上进行的测定显示,纤维蛋白原依赖性增强了凝血酶生成,这依赖于功能性 GPVI。发现 GPVI 的作用取决于纤维蛋白聚合。结合测定显示 GPVI-Fc 与纤维蛋白之间存在特异性相互作用,该相互作用被 Fab 9O12 抑制。该 Fab 还降低了血小板在低(300 s(-1)) 和高(1500 s(-1)) 壁剪切速率下对纤维蛋白的黏附。黏附于纤维蛋白的血小板显示出形态变化、促凝磷脂的暴露以及小血栓的形成。当在富含纤维蛋白的预先形成的血栓上以 1500 s(-1) 的速度灌注已被水蛭素化的血液时,Fab 9O12 将血小板的募集减少了多达 85%。这项研究确定了 GPVI 作为聚合纤维蛋白的血小板受体,具有 2 个主要功能:(1)增强凝血酶生成;(2)募集循环血小板到血栓中。GPVI 的这些迄今为止尚未被认识到的特性赋予其在血栓生长和稳定化中的关键作用。